The Office of Technology Licensing was established in 1970 to transfer technologies developed at Stanford. Find out more about OTL's history, mission, staff, and statistics.

Login to TechFinder » 

Hybridomas 3B12, an Anti-Human Leucocyte Reagent, and Hybridoma 4H9, an Anti-Human T Cell Reagent


Stanford Reference:

82-068


Abstract


Hybridoma 4H9 can be used as an antileukocyte reagent capable of recognizing T-cell leukemia and distinguishing it from other forms of acute leukemia. Hybridoma 3B12 can also be used as an antileukocyte reagent distinquishing leukemia lymphoms from other forms of malignancy.

Innovators & Portfolio



Date Released

 6/8/2009
 

Licensing Contact


Brenda Martino, Biological Materials Specialist
(650) 725-9119 (Direct)
Login to Request Information

[-] Map/Timeline

78-017 Monoclonal Antibodies: 11-6 anti-Ig-5b, 11-5 anti-I-A (2), 11-4 anti-H-2Kk, 11-3 anti-I-A917), 10-4 anti-Ig-5a, H-12 anti-THY 1.2
79-066 Mouse Anti-Human Hybridomas L243, L17F15
82-008 A Monoclonal Antibody Specific For Mouse Granulocytes

more technologies

Related Keywords


research tool   research tool: antibody   leukemia   research tool: cell line   
 

   

  

Also of Interest...
78-017 Monoclonal Antibodies: 11-6 anti-Ig-5b, 11-5 anti-I-A (2), 11-4 anti-H-2Kk, 11-3 anti-I-A917), 10-4 anti-Ig-5a, H-12 anti-THY 1.2
79-066 Mouse Anti-Human Hybridomas L243, L17F15
82-008 A Monoclonal Antibody Specific For Mouse Granulocytes

Recently Viewed...
S82-068 Hybridomas 3B12